세계 청진기 시장 – 2023-2030

Global Stethoscope Market - 2023-2030

상품코드DMMD1261
발행기관DataM Intelligence
발행일2023.01.05
페이지 수200 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

시장 개요
전 세계 청진기 시장 규모는 2022년 YY백만 달러였으며, 2030년까지 YY백만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 5.6%입니다.
청진기는 심장, 폐, 장 등 신체 내부 장기의 소리를 증폭시켜 들을 수 있게 해줍니다. 각 장기의 소리는 의사가 환자 진찰 시 듣는 "표준" 주파수 범위를 가지고 있습니다.
시장 동향
고령 인구 증가와 이와 관련된 만성 질환은 전 세계 청진기 시장 성장을 촉진합니다.
전 세계적으로 고령 인구가 증가하고 노화 관련 만성 질환이 증가함에 따라 시장 성장이 가속화될 것입니다.
미국 노인협회(National Council on Aging, Inc.)에 따르면 65세 이상 성인의 약 80%가 하나 이상의 질환을 앓고 있으며, 68%는 두 가지 이상의 질환을 앓고 있습니다. 노인에게 가장 흔한 질환으로는 만성 폐쇄성 폐질환(COPD), 심부전, 만성 신장 질환(CKD), 허혈성 심장 질환(또는 관상동맥 질환), 고혈압 등이 있습니다. 고령 인구의 증가와 이와 관련된 만성 질환의 증가는 예측 기간 동안 전 세계 청진기 시장의 성장을 촉진할 것입니다. 예를 들어, 미국 경제사회국에 따르면 2020년 65세 이상 인구는 약 7억 2,700만 명이었으며, 2050년에는 15억 명에 이를 것으로 예상됩니다. 전 세계 65세 이상 인구 비율은 2050년까지 전체 인구의 16%에 달할 것으로 전망됩니다. 미국 국립보건원(NIH)에 따르면 2030년까지 85세 이상 인구는 급격히 증가할 것입니다.
또한, 미국 폐협회(American Lung Association)에 따르면 2020년에는 1,250만 명, 즉 성인의 5.0%가 COPD(만성 폐쇄성 폐질환, 만성 기관지염 또는 폐기종) 진단을 받았다고 보고했습니다. 65세 이상 연령층에서 발병률이 젊은 연령층보다 높았습니다. 미국 심장협회(American Heart Association, Inc.)의 2022년 심장 질환 및 뇌졸중 통계 업데이트 자료에 따르면, 2020년 심혈관 질환(CVD)으로 인해 전 세계적으로 약 1,905만 명이 사망했습니다. 따라서 위의 데이터는 고령 인구 증가와 이와 관련된 만성 질환이 예측 기간 동안 전 세계 청진기 시장의 성장을 견인할 것임을 시사합니다.
높은 가격과 숙련된 의료 전문가 부족은 전 세계 청진기 시장 성장을 저해할 것입니다.
일부 최첨단 기술의 청진기는 가격이 매우 높아 일부 의료 전문가만이 구매할 수 있습니다. 마찬가지로, 전문 의료 인력 부족 또한 시장 성장을 저해하는 요인입니다. 공급업체의 부족과 고급 제품에 대한 불충분한 이해는 업계 성장을 저해할 것입니다.
COVID-19 영향 분석
COVID-19 팬데믹으로 인해 의료 지원 수요가 증가했으며, COVID-19는 호흡기 질환이므로 치료 환경에서 폐와 심장에 대한 관심 확대가 중요합니다. 또한, 이러한 특수한 상황으로 인해 기존 치료법으로는 치료하기 어려운 다양한 결과가 발생함에 따라 기술 기반 의료 솔루션에 대한 요구가 증가하고 있습니다. 무선 청진기는 전염 위험을 최소화하면서 이례적인 질병을 치료하는 데 필수적인 요소이며, 전 세계적인 기술 붐을 이끌고 있습니다. 따라서 의료 지원 수요 증가와 팬데믹으로 인한 청진기 혁신은 세계 시장에 긍정적인 영향을 미쳤습니다.
세그먼트 분석
전자 청진기는 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
전자 청진기는 신체 소리를 전자적으로 증폭합니다. 음향 신호가 전자적으로 전송되므로 무선이 가능하고, 소음 감소 기능을 제공하며, 컴퓨터와 연동하여 추가 분석 및 저장이 가능합니다. 전자 청진기는 향후 가장 큰 시장으로 성장할 것으로 예상됩니다. 신제품 개발 및 시장 출시로 인해 예측 기간 동안 높은 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다. 예를 들어, 2021년 8월 Eko Devices, Inc.는 DUO ECG + 디지털 청진기를 출시했습니다. 이 2-in-1 전자 청진기는 심장의 전기 활동을 추적하며 병원의 전자 건강 기록과 통합할 수 있습니다. 마찬가지로, 2020년 Thinklabs One은 COVID-19 팬데믹 기간 동안 의료 전문가의 안전을 보장하는 기술적으로 정교한 디지털 청진기인 Safe Distance Auscultation™을 출시했습니다. 또한, 2020년 4월 폴란드의 원격 의료 혁신 기업인 StethoMe는 유럽의 주요 원격 의료 제공업체인 MaQuestionMedicale 및 HomeDoctor와의 협력을 통해 인공지능 무선 청진기를 출시했습니다.
마찬가지로, 2022년 4월 모할리에 위치한 첨단 컴퓨팅 개발 센터(C-DAC)는 원격지에 있는 의사가 환자의 심장 박동을 진단할 수 있는 무선 전자 청진기를 설계했습니다. 또한, 2022년 4월 이스라엘 스타트업은 사놀라(Sanolla Ltd.)는 자사의 스마트 초저주파 청진기 Vox에 대해 미국 식품의약국(FDA) 510(k) 승인을 받았습니다. 따라서 위에서 언급한 데이터는 제품 개발 및 출시 증가가 예측 기간 동안 전자 청진기 부문의 성장에 기여하고 있음을 보여줍니다.
지리적 분석
북미 지역은 전 세계 청진기 시장을 주도하고 있습니다.
다양한 정부 및 비정부 기관의 심장 및 폐 질환에 대한 인식과 이해 증진 노력은 북미 청진기 시장의 높은 연평균 성장률(CAGR)을 견인하고 있습니다. 예를 들어, 미국 질병통제예방센터(CDC)와 메디케어 및 메디케이드 서비스 센터(CMS)의 공동 노력으로 5년 안에 100만 건의 심장마비를 예방하기 위한 "밀리언 하츠 2022(Million Hearts 2022)"라는 국가적 계획이 추진되고 있습니다. 마찬가지로, 미국 국립심장폐혈연구소(NHLBI)는 만성 폐쇄성 폐질환(COPD) 및 그 위험 요인에 대한 인식과 이해를 높이기 위한 "더 많이 배우고, 더 잘 숨쉬세요(Learn More, Breathe Better)"라는 국가 캠페인을 시작했습니다. 또한 이 캠페인은 조기 발견 및 치료를 통해 질병 진행 속도를 늦추는 데 기여합니다. 질병 치료 및 삶의 질 향상에 기여하고 있습니다.
또한, 이 지역의 다양한 시장 개발 동향도 북미 청진기 시장 성장에 기여하고 있습니다. 예를 들어, 글로벌 헬스케어 기술 파트너인 eMurmur는 2021년 11월, 첨단 디지털 청진(청진기 기술)을 위한 세계 최초의 오픈 소프트웨어 플랫폼을 출시했으며, 현재 미국에서 이용 가능합니다. 마찬가지로, Sanolla는 2022년 4월, AI 기반 VoqX 초저주파 청진기를 미국에서 임상용으로 출시했습니다. 또한, HD Medical은 2021년 6월, 주력 제품인 HD Steth를 미국 내 주요 온라인 청진기 및 의료 제품 유통업체 중 하나인 Stethoscope.com을 통해 온라인으로 판매하기 시작했습니다.
더불어, 북미 지역의 병원 방문 횟수 증가는 북미가 전 세계 청진기 시장을 주도하는 요인으로 작용하고 있습니다. 미국 질병통제예방센터(CDC)에 따르면, 2020년 미국 성인의 약 83.4%가 의료 전문가를 방문했습니다. 미국의 병원 방문 횟수는 다음과 같습니다. 8억 6,040만 건의 청진이 이루어졌으며, 이 중 51.2%가 1차 진료 의사를 방문했습니다. 따라서 위의 데이터는 북미가 예측 기간 동안 전 세계 청진기 시장을 주도할 것임을 시사합니다.
경쟁 환경
청진기 시장은 주요 지역 및 글로벌 업체들의 존재로 인해 경쟁이 비교적 치열합니다. 주요 업체로는 Welch Allyn, 3M, American Diagnostic Corporation, EKuore, Dongjin Medical Co. Ltd, Cardionics, Eko Devices, Medline Industries Inc., Smiths Medical 및 GF Health Products Inc. 등이 있습니다. 이들 주요 업체는 혁신, 신제품 출시, 협력, 인수 및 제휴를 통해 시장 점유율을 유지하고 있습니다. 예를 들어, 2020년 10월 3M과 Eko는 3M의 Littmann 청진기와 Eko의 디지털 혁신 기술을 결합하기 위한 파트너십을 체결했습니다.

3M
개요:
3M은 세계적인 선도 제조업체입니다. 전 세계적으로 사업을 운영하고 있으며, 미국 미네소타주 세인트폴에 본사를 두고 있습니다. 1902년 6월 13일에 설립된 3M은 다양한 브랜드로 6만여 가지의 제품을 취급합니다. 제품군은 접착제, 연마재, 라미네이트, 방화재, 개인 보호 장비, 윈도우 필름, 페인트 보호 필름, 치과 및 교정 제품, 전기 및 전자 연결 및 절연 재료, 의료 제품, 자동차 관리 제품, 전자 회로, 헬스케어 소프트웨어, 광학 필름 등을 포함합니다.
제품 포트폴리오:
3M의 청진기 제품 포트폴리오에는 3M Littmann CORE 디지털 청진기가 있습니다. 3M Littmann CORE 디지털 청진기는 최대 40배 증폭(피크 주파수 기준, 아날로그 모드 대비), 능동형 소음 제거, 앱 내 음파 시각화 및 기타 강력한 기능을 제공하여 환자의 건강 상태를 더욱 명확하게 파악할 수 있도록 개발되었습니다.
글로벌 청진기 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량으로 구성되어 있습니다.

보고서 요약(영어 원문)

Market Overview
The global stethoscope market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 5.6% during the forecast period (2023-2030).
The stethoscope allows the amplification of internal body sounds from the heart, lungs, and bowls. Every internal organ sound has a “standard” frequency range that doctors listen to during patient checkups.
Market Dynamics
The rising geriatric population and related chronic diseases promote the global stethoscope market growth.
The growing geriatric population and age-related chronic diseases worldwide will fuel the market growth.
According to the National Council on Aging, Inc., around 80% of adults 65 and older have at least one condition, while 68% have two or more. A few of the most common conditions among older adults are Chronic obstructive pulmonary disease (COPD), Heart failure, chronic kidney disease (CKD), Ischemic heart disease (or coronary heart disease), Hypertension (high blood pressure), and others. The growing geriatric population and related chronic cases fuel the global stethoscope market growth during the forecast period. For instance, according to the United States Department of Economics and Social Affairs, about 727 million people aged 65 and over in 2020 are estimated to reach 1.5 billion by 2050. share of the population 65 and above globally is expected to be 16% by 2050. According to NIH, by 2030, the population of people aged 85 and over will rise rapidly.
Moreover, according to the American Lung Association, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema. Rates were higher among those 65 and older compared to younger age groups. According to the 2022 heart disease and Stroke Statistics Update Fact Sheet from American Heart Association, Inc., CVD accounted for approximately 19.05 million global deaths in 2020. Thus, the above data indicate that the growing geriatric population and related chronic diseases will drive the growth of the worldwide stethoscope market during the forecasted period.
The high cost and dearth of skilled healthcare professionals will hamper the global Stethoscope market growth.
However, the high cost of some variants and the dearth of skilled healthcare professionals will be a market-restraining aspect. Some of the cutting-edge technology variants are costly, and a few healthcare professionals cannot afford them. Likewise, the shortage of professional healthcare providers and inadequate understanding of high-end products will hinder the industry's growth.
COVID-19 Impact Analysis
Because of the COVID-19 pandemic, the need for healthcare assistance is raised and since COVID-19 is a respiratory disease, expanding attention to the lungs and heart in therapeutic circumstances is vital. Again, tech-enabled healthcare answers are being pursued when this unique situation leads to different outcomes that are challenging to treat with existent practices. Wireless stethoscopes are essential to the worldwide technology boom for treating this unusual disease with minimal risk of transmission. Therefore, the increased need for healthcare assistance and pandemic-driven innovations in stethoscopes has positively impacted the global market.
Segment Analysis
The electronic stethoscope is predicted to grow at the fastest CAGR during the forecast period (2022-2029)
An electronic stethoscope electronically amplifies body sounds. Since the sound signals are transmitted electronically, they can be wireless, provide noise reduction and interfaced with computers, thereby can be further investigated and stored for future usefulness. Electronic stethoscopes are anticipated to boost at a high CAGR during the projection years owing to the new product developments and introductions into the market. According to For instance, in August 2021, Eko Devices, Inc. launched its DUO ECG + Digital Stethoscope. This two-in-one electronic stethoscope tracks electrical activity and can be integrated with hospital electronic health records. Similarly, in 2020, Thinklabs One introduced Safe Distance AuscultationTM, a technologically sophisticated digital stethoscope that allows healthcare experts to be safe during COVID-19. Likewise, in April 2020, Polish telemedicine innovations company StethoMe launched its artificial intelligence wireless stethoscope after its current collaborations with MaQuestionMedicale and HomeDoctor, prominent European telemedicine providers.
Similarly, in April 2022, the Centre for Development of Advanced Computing (C-DAC) based in Mohali designed a wireless electronic stethoscope that allows doctors from remote locations to diagnose patients' heartbeats. Again, in April 2022, Israeli startup Sanolla Ltd. received the United States Food and Drug Administration 510(k) clearance for its smart-infrasound stethoscope Vox. Thus, the abovementioned data indicates that the increasing product developments and introductions contribute to the growth of the electronic stethoscope segment in the forecasted period.
Geographical Analysis
The North American region dominates the global Stethoscope market.
The initiatives by various government and non-government organizations to raise awareness & understanding of cardiac and pulmonary diseases are fueling the North American stethoscope market growth at a high CAGR. For example, a national initiative called "Million Hearts 2022" is being followed to avert 1 million heart attacks within five years. It is a joint endeavor of the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services. Likewise, the National Heart, Lung, and Blood Institute has started a national campaign: Learn More, Breathe Better, to expand awareness & understanding of COPD and its risk factors. Additionally, this campaign supports earlier detection and treatment in slowing the disease and enhancing the quality of life.
Furthermore, different market developments in this region also contribute to the North American stethoscope market growth. For instance, in November 2021, eMurmur, a global healthcare technology partner, released the world's first open software platform for advanced digital auscultation (stethoscope technology), presently available in the United States. Similarly, in April 2022, Sanolla introduced the AI-ready VoqX infrasound stethoscope for clinical use in the United States. Again, in June 2021, HD Medical made its flagship product, HD Steth, available online through Stethoscope.com, one of the leading online stethoscope and medical product distributors in the United States.
Additionally, the growing number of hospital visits in North America ensures the hold of North America over the global stethoscope market. According to the CDC, about 83.4% of adults visited a healthcare professional in the U.S. in 2020. The number of visits in the U.S. was 860.4 million, and the percentage of visits made to primary care physicians was 51.2%. Therefore, the above data indicate that North America will dominate the global stethoscope market throughout the forecast period.
Competitive Landscape
The Stethoscope market is moderately competitive due to the presence of key local and global players. Some key players are Welch Allyn, 3M, American Diagnostic Corporation, EKuore, Dongjin Medical Co. Ltd, Cardionics, Eko Devices, Medline Industries Inc., Smiths Medical and GF Health Products Inc. The key players keep the majority of their market share to themselves through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in October 2020, 3M and Eko formed a partnership to combine 3M’s Littmann stethoscope with Eko’s digital innovations.
3M
Overview:
3M is a leading manufacturer all over the world. It has a global presence and is headquartered in Saint Paul, Minnesota, the United States, which was founded on June 13, 1902. 3M deals with 60,000 various products under many brands; the product categories are adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films.
Product Portfolio:
The 3M product portfolio of Stethoscope has 3M Littmann CORE Digital Stethoscope: The 3M Littmann CORE Digital Stethoscope delivers up to 40x amplification (at peak frequency versus analog mode), active noise cancellation, in-app sound wave visualization and other powerful features developed to give a clearer picture of patient health.
The global stethoscope market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Geriatric Population
4.1.1.2. Innovations And Developments
4.1.2. Restraints
4.1.2.1. High Cost and Lack of Healthcare Professionals
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Electronic
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Acoustic
8. By Design
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
8.1.2. Market Attractiveness Index, By Design
8.2. Single Head
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Double Head
8.4. Triple Head
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals And Clinics
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Healthcare Institutions
9.4. Ambulatory surgical centers (ASCs)
9.5. Home care Settings
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Product Benchmarking
11.3. Key Developments and Strategies
12. Company Profiles
12.1. 3M
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Welch Allyn
12.3. American Diagnostic Corporation
12.4. EKuore
12.5. Dongjin Medical Co. Ltd
12.6. Cardionics
12.7. Eko Devices
12.8. Medline Industries Inc.
12.9. Smiths Medical
12.10. GF Health Products Inc.
LIST NOT EXHAUSTIVE
13. DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

3M, Welch Allyn, American Diagnostic Corporation, EKuore, Dongjin Medical Co. Ltd, Cardionics, Eko Devices, Medline Industries Inc., Smiths Medical, GF Health Products Inc.

표 목록 (Tables)

List of Tables

Table No. 1 Global Stethoscope Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table No. 2 Global Stethoscope Market Value, By End User, 2023, 2027 & 2031 ($ Million)

Table No. 3 Global Stethoscope Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table No. 4 Global Stethoscope Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table No. 5 Global Stethoscope Market Value, By Product Type, 2022-2031 ($ Million)

Table No. 6 Global Stethoscope Market Value, By Design, 2023, 2027 & 2031 ($ Million)

Table No. 7 Global Stethoscope Market Value, By Design, 2022-2031 ($ Million)

Table No. 8 Global Stethoscope Market Value, By End User, 2023, 2027 & 2031 ($ Million)

Table No. 9 Global Stethoscope Market Value, By End User, 2022-2031 ($ Million)

Table No. 10 Global Stethoscope Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table No. 11 Global Stethoscope Market Value, By Region, 2022-2031 ($ Million)

Table No. 12 North America Stethoscope Market Value, By Product Type, 2022-2031 ($ Million)

Table No. 13 North America Stethoscope Market Value, By Design, 2022-2031 ($ Million)

Table No. 14 North America Stethoscope Market Value, By End User, 2022-2031 ($ Million)

Table No. 15 North America Stethoscope Market Value, By Country, 2022-2031 ($ Million)

Table No. 16 South America Stethoscope Market Value, By Product Type, 2022-2031 ($ Million)

Table No. 17 South America Stethoscope Market Value, By Design, 2022-2031 ($ Million)

Table No. 18 South America Stethoscope Market Value, By End User, 2022-2031 ($ Million)

Table No. 19 South America Stethoscope Market Value, By Country, 2022-2031 ($ Million)

Table No. 20 Europe Stethoscope Market Value, By Product Type, 2022-2031 ($ Million)

Table No. 21 Europe Stethoscope Market Value, By Design, 2022-2031 ($ Million)

Table No. 22 Europe Stethoscope Market Value, By End User, 2022-2031 ($ Million)

Table No. 23 Europe Stethoscope Market Value, By Country, 2022-2031 ($ Million)

Table No. 24 Asia-Pacific Stethoscope Market Value, By Product Type, 2022-2031 ($ Million)

Table No. 25 Asia-Pacific Stethoscope Market Value, By Design, 2022-2031 ($ Million)

Table No. 26 Asia-Pacific Stethoscope Market Value, By End User, 2022-2031 ($ Million)

Table No. 27 Asia-Pacific Stethoscope Market Value, By Country, 2022-2031 ($ Million)

Table No. 28 Middle East & Africa Stethoscope Market Value, By Product Type, 2022-2031 ($ Million)

Table No. 29 Middle East & Africa Stethoscope Market Value, By Design, 2022-2031 ($ Million)

Table No. 30 Middle East & Africa Stethoscope Market Value, By End User, 2022-2031 ($ Million)

Table No. 31 3M: Overview

Table No. 32 3M: Product Portfolio

Table No. 33 3M: Key Developments

Table No. 34 Welch Allyn: Overview

Table No. 35 Welch Allyn: Product Portfolio

Table No. 36 Welch Allyn: Key Developments

Table No. 37 American Diagnostic Corporation: Overview

Table No. 38 American Diagnostic Corporation: Product Portfolio

Table No. 39 American Diagnostic Corporation: Key Developments

Table No. 40 EKuore: Overview

Table No. 41 EKuore: Product Portfolio

Table No. 42 EKuore: Key Developments

Table No. 43 Dongjin Medical Co. Ltd: Overview

Table No. 44 Dongjin Medical Co. Ltd: Product Portfolio

Table No. 45 Dongjin Medical Co. Ltd: Key Developments

Table No. 46 Cardionics: Overview

Table No. 47 Cardionics: Product Portfolio

Table No. 48 Cardionics: Key Developments

Table No. 49 Eko Devices: Overview

Table No. 50 Eko Devices: Product Portfolio

Table No. 51 Eko Devices: Key Developments

Table No. 52 Medline Industries Inc.: Overview

Table No. 53 Medline Industries Inc.: Product Portfolio

Table No. 54 Medline Industries Inc.: Key Developments

Table No. 55 Smiths Medical: Overview

Table No. 56 Smiths Medical: Product Portfolio

Table No. 57 Smiths Medical: Key Developments

Table No. 58 GF Health Products Inc.: Overview

Table No. 59 GF Health Products Inc.: Product Portfolio

Table No. 60 GF Health Products Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure No. 1 Global Stethoscope Market Share, By Product Type, 2022 & 2031 (%)

Figure No. 2 Global Stethoscope Market Share, By Design, 2022 & 2031 (%)

Figure No. 3 Global Stethoscope Market Share, By End User, 2022 & 2031 (%)

Figure No. 4 Global Stethoscope Market Share, By Region, 2022 & 2031 (%)

Figure No. 5 Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 6 Global Stethoscope Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure No. 7 Acoustic: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 8 Electronic: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 9 Global Stethoscope Market Share, By Design, 2022 & 2031 (%)

Figure No. 10 Single Head: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 11 Double Head: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 12 Triple Head: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 13 Global Stethoscope Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure No. 14 Hospitals And Clinics: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 15 Healthcare Institutions: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 16 Ambulatory surgical centers (ASCs): Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 17 Home care settings: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 18 Others: Global Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 19 Global Stethoscope Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure No. 20 North America Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 21 North America Stethoscope Market Share, By Product Type, 2022 & 2031 (%)

Figure No. 21 North America Stethoscope Market Share, By Design, 2022 & 2031 (%)

Figure No. 22 North America Stethoscope Market Share, By End User, 2022 & 2031 (%)

Figure No. 23 North America Stethoscope Market Share, By Country, 2022 & 2031 (%)

Figure No. 24 South America Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 25 South America Stethoscope Market Share, By Product Type, 2022 & 2031 (%)

Figure No. 26 South America Stethoscope Market Share, By Design, 2022 & 2031 (%)

Figure No. 27 South America Stethoscope Market Share, By End User, 2022 & 2031 (%)

Figure No. 28 South America Stethoscope Market Share, By Country, 2022 & 2031 (%)

Figure No. 29 Europe Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 30 Europe Stethoscope Market Share, By Product Type, 2022 & 2031 (%)

Figure No. 31 Europe Stethoscope Market Share, By Design, 2022 & 2031 (%)

Figure No. 32 Europe Stethoscope Market Share, By End User, 2022 & 2031 (%)

Figure No. 33 Europe Stethoscope Market Share, By Country, 2022 & 2031 (%)

Figure No. 34 Asia-Pacific Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 35 Asia-Pacific Stethoscope Market Share, By Product Type, 2022 & 2031 (%)

Figure No. 36 Asia-Pacific Stethoscope Market Share, By Design, 2022 & 2031 (%)

Figure No. 37 Asia-Pacific Stethoscope Market Share, By End User, 2022 & 2031 (%)

Figure No. 38 Asia-Pacific Stethoscope Market Share, By Country, 2022 & 2031 (%)

Figure No. 39 Middle East & Africa Stethoscope Market Value, 2022-2031 ($ Million)

Figure No. 40 Middle East & Africa Stethoscope Market Share, By Product Type, 2022 & 2031 (%)

Figure No. 41 Middle East & Africa Stethoscope Market Share, By Design, 2022 & 2031 (%)

Figure No. 42 Middle East & Africa Stethoscope Market Share, By End User, 2022 & 2031 (%)

Figure No. 43 3M: Financials

Figure No. 44 Welch Allyn: Financials

Figure No. 45 American Diagnostic Corporation: Financials

Figure No. 46 EKuore: Financials

Figure No. 47 Dongjin Medical Co. Ltd: Financials

Figure No. 48 Cardionics: Financials

Figure No. 49 Eko Devices: Financials

Figure No. 50 Medline Industries Inc.: Financials

Figure No. 51 Smiths Medical: Financials

Figure No. 52 GF Health Products Inc.: Financials